NIT-OCCLUD PDA Phase II Sentinel Trial

NACompletedINTERVENTIONAL
Enrollment

357

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2007

Study Completion Date

October 31, 2007

Conditions
Ductus Arteriosus, Patent
Interventions
DEVICE

Transcatheter PDA Coil

The Nit-Occlud PDA is a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus with a minimum angiographic diameter \< 4 mm.

Trial Locations (15)

19134

St. Christopher's Hospital for Children, Philadelphia

19899

A.I. Dupont Hospital for Children, Wilmington

20010

Children's National Medical Center, Washington D.C.

43205

Columbus Children's Hospital, Columbus

44308

Children's Hospital of Akron, Akron

52242

Children's Hospital of Iowa, Iowa City

60453

Hope Children's Hospital, Oak Lawn

61603

Children's Hospital of Illinois, Peoria

75235

Children's Medical Center of Dallas, Dallas

78411

Driscoll Children's Hospital, Corpus Christi

90095

Mattel Children's Hospital at UCLA, Los Angeles

92868

Children's Hospital of Orange County, Orange

93638

Children's Hospital Central California, Madera

98105

Children's Hospital and Regional Medical Center Seattle, Seattle

46202-5225

Riley Hospital for Children, Indianapolis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PFM Medical, Inc

INDUSTRY

NCT00828334 - NIT-OCCLUD PDA Phase II Sentinel Trial | Biotech Hunter | Biotech Hunter